SEARCH

SEARCH BY CITATION

A

abuse; suicide, self-mutilation and dissociation 119

actigraph

circadian rhythms in acute care unit 53

hangover effects of benzodiazepines 303

sleep–wake behavior in ATC (Short Communication) 539

addiction; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

adolescent onset schizophrenia; minor physical anomalies in schizophrenia 17

adolescents

catatonia in childhood and adolescence 129

citalopram in pediatric Obsessive-Compulsive Disorder 405

suicide, self-mutilation and dissociation 119

adverse reaction; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

air traffic controllers; sleep–wake behavior in ATC (Short Communication) 539

alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes of north-east Thais 37

alcohol use disorders; alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes of north-east Thais 37

alcoholism; gabapentin vs trazodone in alcoholics (Short Communication) 542

aldehyde dehydrogenase-2 and alcohol dehydrogenase-2 of north-east Thais 37

alienation; pathogenesis of schizophrenia (Review Article) 3

amitriptyline; dose individualization 580

amygdala; pathogenesis of schizophrenia (Review Article) 9

anterior cingulate gyrus; pathogenesis of schizophrenia (Review Article) 3

anticonvulsants; mood stabilization in children with BD 504

anxiety disorder; Japanese SCID-II 532

arousal level; attention and arousal level in schizophrenia 472

arousals; obstructive sleep apnea; hypopnea syndrome 197

Association of low dose trazodone treatment with aggravated angle-closure glaucoma (Letter to the Editor) 127

association study

DAP-1 gene in schizophrenia (Short Communication) 545

tumor necrosis factor-α polymorphism and schizophrenia 399

attention and arousal level in schizophrenia 472

attention deficit–hyperactivity disorder

comorbidity in 457

parent training for attention-deficit; hyperactivity disorder children 275

attitude; distress due to hallucinations in schizophrenia 517

auditory perception; schizotypy and auditory discrimination 391

augmentation; tandospirone augmentation of antidepressant 183

autism

catatonia in childhood and adolescence 129

childhood Autism Rating Scale—Tokyo Version for screening pervasive developmental disorders 113

autistic disorder

bone marrow transplantation 311

developmental quotient and intelligence quotient in autism (Short Communication) 231

‘Awakenings’ in demented patients (Letter to the Editor) 237

B

Baum test; schizophrenia and tree-drawing morphology 347

behavioral disturbances in dementia 569

behavioural patterns; Benton Visual Retention Test 409

behavioural therapy; open-system social skills training at a general hospital 295

Benton Visual Retention Test; Benton Visual Retention Test 409

benzodiazepines

effects on sleep electroencephalogram 97

hangover effects of benzodiazepines 303

hypothermia and zotepine 369

bilateral asymmetry; symmetry reversal in schizophrenia 353

biological predictor; biological predictors of lithium response (Review Article) 243

bipolar disorder; biological predictors of lithium response (Review Article) 243

bipolar II disorder; unipolar major depressive disorder 497

bipolar spectrum; unipolar major depressive disorder 497

Body Attitude Test 511

body dissatisfaction; Japanese Body Attitude Test 511

body dysmorphic disorder; cenesthopathy in adolescence 23

bone marrow transplantation

bone marrow transplantation 311

psychological factors and survival in bone marrow transplantation patients 91

borderline personality disorder

bone marrow transplantation 311

nightmare disorder and dissociative disorder 575

bradykinin and somatization disorder (Letter to the Editor) 609

Braille alexia; braille alexia and visual hallucination (Short Communication) 227

brain function; schizophrenia and tree-drawing morphology 347

breast cancer; emotional inhibition in breast cancer patients 289

bus drivers; substance abuse in commercial drivers 425

C

calcarine atrophy; braille alexia and visual hallucination (Short Communication) 227

carbamazepine; transient lesion in the splenium of the corpus callosum (Letter to the Editor) 550

case–control studies; rehospitalization of schizophrenia 555

catatonia; catatonia in childhood and adolescence 129

cenesthopathic schizophrenia; cenesthopathy in adolescence 23

cenesthopathy; cenesthopathy in adolescence 23

central nervous system; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

cerebral blood flow

cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

regional cerebral blood flow in delirium patients (Short Communication) 337

child; catatonia in childhood and adolescence 129

child abuse

personality and early experiences 323

nightmares and dissociative experiences 139

Childhood Autism Rating Scale; Childhood Autism Rating Scale—Tokyo Version for screening pervasive developmental disorders 113

childhood onset schizophrenia; minor physical anomalies in schizophrenia 17

children; citalopram in pediatric Obsessive-Compulsive Disorder 405

Children Depression Inventory; adjustment of pediatric cancer patients 75

children with attention-deficit; hyperactivity disorder; parent training for attention-deficit; hyperactivity disorder children 275

Children's depression Inventory; school avoidance and depression 464

chronic fatigue syndrome

chronic fatigue syndrome 361

circadian rhythms; circadian rhythms in acute care unit 53

circadian typology; sleep–wake behavior in ATC (Short Communication) 539

citalopram; citalopram in pediatric Obsessive-Compulsive Disorder 405

classification; classification of personality disorders 417

clomipramine; tandospirone augmentation of antidepressant 183

closed-eye movements; attention and arousal level in schizophrenia 472

clozapine; improvement of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine (Letter to the Editor) 235

cognition; sleep deprivation, cognition and P300 490

cognitive dysfunction; attention and arousal level in schizophrenia 472

cognitive frame; pathogenesis of schizophrenia (Review Article) 9

cohort studies; predictors of first-onset MDE 523

community care; family support system for schizophrenics 161

comorbidity in ADHD 457

compliance; bone marrow transplantation 311

computer; dose individualization of amitriptyline 580

Confucianism; parent training for attention-deficit; hyperactivity disorder children 275

Continuous Performance Test; Cost and Continuous Performance Test in schizophrenia 371

coping; distress due to hallucinations in schizophrenia 517

cross-cultural comparison; Japanese Social Adjustment Scale-Self Report 441

cross-over phenomenon; attention and arousal level in schizophrenia 472

curve fitting model; classification of personality disorders 417

cytoplasmic inclusions; Machado-Joseph disease 205

D

DAP-1 gene in schizophrenia (Short Communication) 545

delirium

donepezil-responsive alcohol-related prolonged delirium (Letter to the Editor) 603

regional cerebral blood flow in delirium patients (Short Communication) 337

delta wave; delta electroencephalography and heart rate cariability 59

delusion; sulpiride for treatment of delusion of parasitosis (Letter to the Editor) 552

dementia

‘awakenings’ in demented patients (Letter to the Editor) 237

behavioral disturbances in dementia 569

intervention for caregivers and immune function 147

vertical ophthalmoplegia (Short Communication) 447

demographic data; chronic fatigue syndrome 361

depersonalization; cenesthopathy in adolescence 23

depressed mood; HIV-seropositive drug users 251

depression

adjustment of pediatric cancer patients 75

dose and duration of fluvoxamine 177

predictors of first-onset MDE 523

school avoidance and depression 464

depressive disorder; separation and depressive symptoms 215

depressive mixed state; unipolar major depressive disorder 497

desire to be thin; self-physique and eating behaviour 189

developmental quotient; developmental quotient and intelligence quotient in autism (Short Communication) 231

diagnosis; Childhood Autism Rating Scale—Tokyo Version for screening pervasive developmental disorders 113

dieting; self-physique and eating behaviour 189

diffuse neurofibrillary tangles with calcification; Vertical ophthalmoplegia (Short Communication) 447

direct sequencing; DAP-1 gene in schizophrenia (Short Communication) 545

dissociation

nightmares and dissociative experiences 139

suicide, self-mutilation and dissociation 119

dissociative disorders and nightmare disorder 575

dissociative experiences; nightmares and dissociative experiences 139

distress due to hallucinations in schizophrenia 517

donepezil-responsive alcohol-related prolonged delirium (Letter to the Editor) 603

dopamine; pathogenesis of schizophrenia (Review Article) 9

dose individualization of amitriptyline 580

dose-response; dose and duration of fluvoxamine 177

dream anxiety; nightmares and dissociative experiences 139

drug therapy; gabapentin vs trazodone in alcoholics (Short Communication) 542

drug use; HIV-seropositive drug users 251

E

early drop-out; risperidone treatment in Korea 83

early life events; personality and early experiences 323

Eating Attitudes Test-26; self-physique and eating behaviour 189

eating behaviour; self-physique and eating behaviour 189

eating disorder

Japanese Body Attitude Test 511

plasma nitrate and nitrite levels of patients with eating disorders (Letter to the Editor) 343

with hyperthyroidism (Letter to the Editor) 341

economic cost; cost and Continuous Performance Test in schizophrenia 371

ecstasy; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

educational program on public attitudes 595

EEG temporal slow wave: a useful tool in vascular depression (Letter to the Editor) 610

elderly; sleep and depression in the elderly 265

electroencephalogram; interrater reliability in EEG interpretations 485

emotional distress; emotional inhibition in breast cancer patients 289

emotional inhibition; emotional inhibition in breast cancer patients 289

endogenous-juvenile asthenic insufficiency syndrome; Cenesthopathy in adolescence 23

entorhinal cortex; pathogenesis of schizophrenia (Review Article) 9

epilepsy with absence-like and secondarily generalized seizures (Letter to the Editor) 455

esophageal pressure; obstructive sleep apnea; hypopnea syndrome 197

evacuee; psychological distress and disaster 105

evaluation research; educational program on public attitudes 595

excessive daytime sleepiness; excessive daytime sleepiness in high school students (Short Communication) 451

exploratory eye movements

Benton Visual Retention Test 409

in schizophrenia 169

methamphetamine psychosis 433

Eysenck Personality Questionnaire; personality and early experiences 323

F

factor analysis; General Health Questionnaire-12 for Japanese adults 379

Family Adaptability and Cohesion Evaluation Score; primary social withdrawal 586

family characteristics; primary social withdrawal 586

family history; unipolar major depressive disorder 497

family support system; family support system for schizophrenics 161

feelings of school avoidance; school avoidance and depression 464

fingertapping; schizophrenia and hemiparkinsonism 562

flunitrazepam; hangover effects of benzodiazepines 303

fluvoxamine; dose and duration of fluvoxamine 177

fMRI; schizophrenia and hemiparkinsonism 562

frequency distribution; classification of personality disorders 417

frontal lobe epilepsy

and secondarily generalized seizures (Letter to the Editor) 455

post-ictal headache in patients with epilepsy 385

G

gabapentin vs trazodone in alcoholics (Short Communication) 542

gazing time scanning length; exploratory eye movements in schizophrenia 169

gender

General Health Questionnaire-12 for Japanese adults 379

psychological factors and survival in bone marrow transplantation patients 91

General Health Questionnaire

for Japanese adults 379

psychological distress and disaster 105

general hospital; open-system social skills training at a general hospital 295

Geriatric Depression Scale; sleep and depression in the elderly 265

germ-free unit; bone marrow transplantation 311

glaucoma; association of low dose trazodone treatment with aggravated angle-closure glaucoma (Letter to the Editor) 127

Global Assessment Functioning Scale; methamphetamine psychosis 433

group intervention; intervention for caregivers and immune function 147

H

hallucinations

braille alexia and visual hallucination (Short Communication) 227

distress due to hallucinations in schizophrenia 517

phenomenology of hallucinations (Short Communication) 333

schizotypy and auditory discrimination 391

visual and auditory hallucinations with excessive intake of paroxetine (Letter to the Editor) 548

hangover; hangover effects of benzodiazepines 303

happiness; General Health Questionnaire-12 for Japanese adults 379

heart rate variability; delta electroencephalography and heart rate cariability 59

hemiparkinsonism and schizophrenia 562

high school students; self-physique and eating behaviour 189

HIV infection; HIV-seropositive drug users 251

hyperthyroidism; eating disorder (Letter to the Editor) 341

hypothermia; hypothermia and zotepine 369

hypoxic brain damage; prenatal development and schizophrenia 271

I

Ikeda incident; school crisis intervention (Letter to the Editor) 239

immune function; intervention for caregivers and immune function 147

informed consent; catatonia in childhood and adolescence 129

insomnia; gabapentin vs trazodone in alcoholics (Short Communication) 542

intelligence quotient; developmental quotient and intelligence quotient in autism (Short Communication) 231

intensive care; circadian rhythms in acute care unit 53

interhemispheric correlation; symmetry reversal in schizophrenia 353

interleukin-10 gene promoter polymorphism; interleukin-10 gene promoter polymorphism 153

interleukin-4 promoter gene; polymorphisms of interleukin-4 in schizophrenics 283

interleukin-4 receptor gene; polymorphisms of interleukin-4 in schizophrenics 283

interrater reliability in EEG interpretations 485

intoxication; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

islands; family support system for schizophrenics 161

J

Japanese Body Attitude Test 511

Japanese SCID-II 532

K

Kami-shoyo-san is usually used for women (Letter to the Editor) 345

kappa; interrater reliability in EEG interpretations 485

Korea

excessive daytime sleepiness in high school students (Short Communication) 451

interleukin-10 gene promoter polymorphism 153

polymorphisms of interleukin-4 in schizophrenics 283

risperidone treatment in Korea 83

tumor necrosis factor-β polymorphism and major depression 31

L

leukemia; psychological factors and survival in bone marrow transplantation patients 91

light; circadian rhythms in acute care unit 53

lithium; biological predictors of lithium response (Review Article) 243

long term maintenance; risperidone treatment in Korea 83

low birthweight; prenatal development and schizophrenia 271

M

Machado-Joseph disease 205, 607

major depression; subjective and objective sleep 259

major depressive disorder

tandospirone augmentation of antidepressant 183

tumor necrosis factor-β polymorphism and major depression 31

malignant catatonia; catatonia in childhood and adolescence 129

mania; mood stabilization in children with BD 504

Maudsley Personality Inventory; subjective and objective sleep 259

mediation, mood stabilization in children with BD 504

memory organization; pathogenesis of schizophrenia (Review Article) 3

mental disorders; open-system social skills training at a general hospital 295

mental disturbances; bone marrow transplantation 311

mental health

educational program on public attitudes 595

family support system for schizophrenics 161

rehospitalization of schizophrenia 555

mental retardation

comorbidity in ADHD 457

developmental quotient and intelligence quotient in autism (Short Communication) 231

mental support team; school crisis intervention in the Ikeda incident: Organization and activity of the mental support team (Letter to the Editor) 239

methamphetamine psychosis; methamphetamine psychosis 433

Michigan Alcoholism Screening Test; Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes of north-east Thais 37

minor physical anomalies; minor physical anomalies in schizophrenia 17

MMSE; behavioral disturbances in dementia 569

monosymptomatic hypochondriacal psychosis; cenesthopathy in adolescence 23

monozygotic twin; prenatal development and schizophrenia 271

mood stabilization in children with BD 504

morphological analysis; schizophrenia and tree-drawing morphology 347

motor symptom; features of obsessive-compulsive disorder with schizophrenia 67

Multiple Sleep Latency Test; hangover effects of benzodiazepines 303

musical hallucination; musical obsession and clomipamine 47

musical obsession; musical obsession and clomipamine 47

N

natural disaster; psychological distress and disaster 105

natural killer cell activity; intervention for caregivers and immune function 147

neglect; suicide, self-mutilation and dissociation 119

neuroleptic treatment; schizophrenia and hemiparkinsonism 562

neuroleptics; symmetry reversal in schizophrenia 353

neuropsychologic performance; HIV-seropositive drug users 251

nightmare disorder and dissociative disorder 575

nightmares; nightmares and dissociative experiences 139

nitrite levels of patients with eating disorders (Letter to the Editor) 343

NMDA receptor; DAP-1 gene in schizophrenia (Short Communication) 545

nuclear inclusions; Machado-Joseph disease 205

O

obsessive-compulsive disorder

citalopram in pediatric Obsessive-Compulsive Disorder 405

features of obsessive-compulsive disorder with schizophrenia 67

musical obsession and clomipamine 47

obsessive-compulsive symptoms; improvement of symptoms in a patient with schizophrenia treated with clozapine (Letter to the Editor) 235

obstructive sleep apnea 197

occipital lobe epilepsy; post-ictal headache in patients with epilepsy 385

occupational diseases; predictors of first-onset MDE 523

olanzapine

and serotonin toxicity (Letter to the Editor) 241

in refractory schizophrenia 478

rapid onset of dyskinesia (Letter to the Editor) 605

onset; cose and duration of fluvoxamine 177

open-label trial; olanzapine in refractory schizophrenia 478

oxygen desaturation; obstructive sleep apnea; hypopnea syndrome 197

P

pain; sleep and depression in the elderly 265

parasitosis; sulpiride for treatment of delusion of parasitosis (Letter to the Editor) 552

parent training for attention-deficit; hyperactivity disorder children 275

parent–child relationship; separation and depressive symptoms 215

parents; adjustment of pediatric cancer patients 75

patient readmission; rehospitalization of schizophrenia 555

pediatric cancer patients; adjustment of pediatric cancer patients 75

perinatal complications; prenatal development and schizophrenia 271

personality

personality and early experiences 323

school avoidance and depression 464

personality disorder

classification of personality disorders 417

Japanese SCID-II 532

pervasive developmental disorder; cevelopmental quotient and intelligence quotient in autism (Short Communication) 231

pervasive developmental disorders; catatonia in childhood and adolescence 129

pervasive developmental disorders; childhood Autism Rating Scale—Tokyo Version for screening pervasive developmental disorders 113

pharmacogenetics; biological predictors of lithium response (Review Article) 243

pharmacological potency; benzodiazepines effects on sleep electroencephalogram 97

phenomenology of hallucinations (Short Communication) 333

Pittsburgh Sleep Quality Index; sleep and depression in the elderly 265

Plasma nitrate and nitrite levels of patients with eating disorders (Letter to the Editor) 343

polymorphism; DAP-1 gene in schizophrenia (Short Communication) 545

polymorphisms of interleukin-4 in schizophrenics 283

polysomnography; subjective and objective sleep 259

post-ictal headache; post-ictal headache in patients with epilepsy 385

pre-adolescents; mood stabilization in children with BD 504

predictors of first-onset MDE 523

premenstrual dysphoric disorder; venlafaxine for premenstrual disorder 317

prevalence; post-ictal headache in patients with epilepsy 385

primary social withdrawal 586

Proceedings

17th Annual Meeting of Adolescent Psychiatry S33

20th Annual Conference of the Japanese Association for Adolescent Psychotherapy S37

24th Annual Meeting of the Japanese Society of Biological Psychiatry S1

25th Annual Meeting of the Japanese Society of Biological Psychiatry S43

prognosis; psychological factors and survival in bone marrow transplantation patients 91

progressive supranuclear palsy; vertical ophthalmoplegia (Short Communication) 447

psychiatric disorders; substance abuse in commercial drivers 425

psychiatric status rating scales; separation and depressive symptoms 215

psychiatric symptoms; Benton Visual Retention Test 409

psychological distress; psychological distress and disaster 105

psychological status; psychological factors and survival in bone marrow transplantation patients 91

psychological stress; predictors of first-onset MDE 523

psychological trauma; psychological distress and disaster 105

psychometrics; Japanese Social Adjustment Scale-Self Report 441

psychosocial adjustment; adjustment of pediatric cancer patients 75

public attitudes towards mental illness 595

pure obsessional disorder; musical obsession and clomipamine 47

Q

quazepam; hangover effects of benzodiazepines 303

R

rapid onset of dyskinesia induced by olanzapine (Letter to the Editor) 605

reaction time

sleep deprivation, cognition and P300 490

symmetry reversal in schizophrenia 353

rearing; personality and early experiences 323

recovery phase; exploratory eye movements in schizophrenia 169

rehospitalization of schizophrenia 555

relaxation; intervention for caregivers and immune function 147

reliability; General Health Questionnaire-12 for Japanese adults 379

reproducibility of results; Japanese Social Adjustment Scale-Self Report 441

respiratory effects; obstructive sleep apnea; hypopnea syndrome 197

response bias; schizotypy and auditory discrimination 391

restless legs syndrome; sleep and depression in the elderly 265

retinal degeneration; braille alexia and visual hallucination (Short Communication) 227

risk factors; predictors of first-onset MDE 523

risperidone; risperidone treatment in Korea 83

S

schizophrenia

attention and arousal level in schizophrenia 472

Benton Visual Retention Test 409

bone marrow transplantation 311

cost and Continuous Performance Test in schizophrenia 371

DAP-1 gene in schizophrenia (Short Communication) 545

distress due to hallucinations in schizophrenia 517

exploratory eye movements in schizophrenia 169

family support system for schizophrenics 161

features of obsessive-compulsive disorder with schizophrenia 67

hemiparkinsonism 562

interleukin-10 gene promoter polymorphism 153

methamphetamine psychosis 433

minor physical anomalies in schizophrenia 17

pathogenesis of schizophrenia (Review Article) 3

pathogenesis of schizophrenia (Review Article) 9

polymorphisms of interleukin-4 in schizophrenics 283

prenatal development and schizophrenia 271

rehospitalization 555

schizophrenia and tree-drawing morphology 347

schizotypy and auditory discrimination 391

symmetry reversal in schizophrenia 353

improvement of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine (Letter to the Editor) 235

tumor necrosis factor-α polymorphism and schizophrenia 399

schizotypal disorder; pathogenesis of schizophrenia (Review Article) 3

schizotypy; schizotypy and auditory discrimination 391

school avoidance and depression 464

school crisis intervention in the Ikeda incident: Organization and activity of the mental support team (Letter to the Editor) 239

school refusal; school avoidance and depression 464

SCID-II 532

screening test; Childhood Autism Rating Scale—Tokyo Version for screening pervasive developmental disorders 113

seizures; frontal lobe epilepsy with absence-like and secondarily generalized seizures (Letter to the Editor) 455

selective serotonin reuptake inhibitor; dose and duration of fluvoxamine 177

self-monitoring; Schizotypy and auditory discrimination 391

self-mutilation

nightmare disorder and dissociative disorder 575

suicide, self-mutilation and dissociation 119

self-physique; self-physique and eating behaviour 189

senior high school students; excessive daytime sleepiness in high school students (Short Communication) 451

serotonin toxicity and olanzapine (Letter to the Editor) 241

serotonin-norepinephrine re-uptake inhibitor; venlafaxine for premenstrual disorder 317

shiftwork; sleep–wake behavior in ATC (Short Communication) 539

side-effect; cerebral single photon emission computed tomography in ecstasy intoxication (Short Communication) 221

signal detection theory; schizotypy and auditory discrimination 391

simple reaction time; attention and arousal level in schizophrenia 472

skill evaluation; open-system social skills training at a general hospital 295

sleep; subjective and objective sleep 259

sleep deprivation, cognition and P300 490

sleep electroencephalogram; benzodiazepines effects on sleep electroencephalogram 97

sleep electroencephalogram; delta electroencephalography and heart rate cariability 59

sleep habits; excessive daytime sleepiness in high school students (Short Communication) 451

sleep log; subjective and objective sleep 259

sleep–wake behavior in ATC (Short Communication) 539

social adjustment; Japanese Social Adjustment Scale-Self Report 441

social skills training; open-system social skills training at a general hospital 295

social withdrawal; primary social withdrawal 586

sociality-related circuits; pathogenesis of schizophrenia (Review Article) 9

somatization disorder and bradykinin (Letter to the Editor) 609

spectral analysis

benzodiazepines effects on sleep electroencephalogram 97

delta electroencephalography and heart rate cariability 59

stigma; educational program on public attitudes 595

substance use; substance abuse in commercial drivers 425

suicidal behavior; nightmare disorder and dissociative disorder 575

suicide; self-mutilation and dissociation 119

sulpiride for treatment of delusion of parasitosis (Letter to the Editor) 552

survival; psychological factors and survival in bone marrow transplantation patients 91

symptomatology; schizophrenia and tree-drawing morphology 347

I

tandospirone

augmentation of antidepressant 183

‘drug holiday’ effects of tandospirone in a patient with Machado-Joseph disease (Letter to the Editor) 607

taxi drivers; substance abuse in commercial drivers 425

temporal lobe epilepsy; post-ictal headache in patients with epilepsy 385

test–retest reliability; Japanese SCID-II 532

Thais; alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes of north-east Thais 37

thought disorder; cenesthopathy in adolescence 23

time fragments; symmetry reversal in schizophrenia 353

transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine (Letter to the Editor) 550

trauma; suicide, self-mutilation and dissociation 119

trazodone

association of low dose trazodone treatment with aggravated angle-closure glaucoma (Letter to the Editor) 127

vs gabapentin in alcoholics (Short Communication) 542

treatment

biological predictors of lithium response (Review Article) 243

citalopram in pediatric Obsessive-Compulsive Disorder 405

mood stabilization in children with BD 504

treatment-resistant schizophrenia; olanzapine in refractory schizophrenia 478

triazolam; hangover effects of benzodiazepines 303

truth telling of cancer; emotional inhibition in breast cancer patients 289

tumor necrosis factor-α gene polymorphism; tumor necrosis factor-α polymorphism and schizophrenia 399

tumor necrosis factor-β gene polymorphism; tumor necrosis factor-β polymorphism and major depression 31

Type C personality; emotional inhibition in breast cancer patients 289

U

ubiquitin; Machado-Joseph disease 205

unipolar major depressive disorder 497

V

validity; Japanese Social Adjustment Scale-Self Report 441

valproate

hypothermia and zotepine 369

mood stabilization in children with BD 504

vascular depression; EEG temporal slow wave: a useful tool in vascular depression (Letter to the Editor) 610

venlafaxine; venlafaxine for premenstrual disorder 317

vertical gaze palsy; vertical ophthalmoplegia (Short Communication) 447

vigilance; sleep deprivation, cognition and P300 490

visual and auditory hallucinations with excessive intake of paroxetine (Letter to the Editor) 548

vulnerability; methamphetamine psychosis 433

W

Waldrop scale; minor physical anomalies in schizophrenia 17

X

Xenon-enhanced computed tomography; regional cerebral blood flow in delirium patients (Short Communication) 337

Y

Yale-Brown Obsessive-compulsive Scale; features of obsessive-compulsive disorder with schizophrenia 67

young adult; primary social withdrawal 586

Z

zotepine; hypothermia and zotepine 369